
40-year-old reaches millions on TikTok as 'The Workout Witch': I found a 'deep sense of purpose'
To better understand the cause of her chronic pain and insomnia, Liz Tenuto majored in psychology. Her studies led her to psychotherapy for healing, like EMDR, and a better understanding of how the nervous system operates.
While working as a professional dancer after college, a suggestion from her teacher put Tenuto on the path to becoming "The Workout Witch."
"It was actually my ballet teacher who noticed that I was very dissociated when I wasn't dancing," Tenuto, 40, tells CNBC Make It.
"[They] kind of nudged me to take a somatics class."
In 2008, somatic exercises were still pretty new to most people. "For me, it just looked like a bunch of people rolling around in their pajamas on the floor," Tenuto says. "So I was very skeptical at first, especially with an academic background."
Somatic exercises were created to relieve tension from the body and entail moving in slow and mindful ways that shift the focus from how you look to what you feel. Yoga, breathwork and dance are all considered forms of somatic movement.
"It's micro-movements. They're really tiny, and you do very little in a class," Tenuto says. In the sessions she attended, "we maybe did three or four movements in an entire hour and a half class. And it had profound effects."
Somatic movements can be beneficial for a number of reasons, but is most widely touted for its effect on the nervous system.
"Our nervous system has different ways that it can be activated — sympathetic activation, which is fight-flight, and parasympathetic activation, which is freeze or shut down," she says.
In between those two modes of activation is a middle ground called the "ventral vagal state," which is a state of homeostasis. "You're balanced, you're social, you're grounded, you're regulated," she explains.
The polyvagal theory indicates that doing somatic exercises may put you in the ventral vagal state, lead to better emotional regulation and get you out of fight or flight.
"You're just reinforcing safety in your body as you do them over and over again, and you're practicing this regulated state," Tenuto says.
"It's similar to building muscle. As you continue to build those new neural pathways and practice the exercises, that starts to become stronger than some of your trauma responses."
During the Covid-19 shutdown in 2020, Tenuto began uploading videos of herself demonstrating somatic exercises to the social media platform TikTok, which was gaining in popularity at the time.
"I was posting the exercises, really to just hold me accountable for doing one exercise per day. Because at that time, I was having a really hard time just getting out of bed," she says.
"I was very sad at the time. I was going through a divorce."
Tenuto says sharing that daily exercise was the only thing that helped, and she was stunned when her account went from zero followers to 10,000 in just two to three weeks. Today, she's at 2.2 million.
Before the pandemic, Tenuto taught Pilates and somatics classes and had private clients who she guided through injury recovery. Seeing how receptive the audience on TikTok and Instagram were to her videos filled her up with a "deep sense of purpose," she says, and showed that sharing her work online could be just as effective.
Now, Tenuto's somatic therapy demonstrations for healing trauma, alleviating symptoms of anxiety and shifting out of "functional freeze" go viral.
Tenuto deemed herself "The Workout Witch" because "when people experience these exercises, they do think that there's some magic, and some like woo woo stuff going on with them," she says.
"I wish there was, but it's really just using neuroscience with movement."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

9 minutes ago
FDA requires updated warning about rare heart risk with COVID shots
WASHINGTON -- WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men. Myocarditis, a type of heart inflammation that is usually mild, emerged as a complication after the first shots became widely available in 2021. Prescribing information from both Pfizer and Moderna already advises doctors about the issue. In April, the FDA sent letters to both drugmakers asking them to update and expand the warnings to add more detail about the problem and to cover a larger group of patients. While the FDA can mandate label changes, the process is often more of a negotiation with companies. Specifically, the new warning lists the risk of myocarditis as 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old. The label also notes that the problem has been most common among males ages 12 to 24. The previous label said the problem mostly occurs in 12- to 17-year-olds. The FDA's labeling change appears to conflict with some prior findings of scientists elsewhere in the U.S. government. The Centers for Disease Control and Prevention previously concluded there was no increased risk of myocarditis detected in government vaccine injury databases for COVID-19 shots dating back to 2022. Officials also noted that cases tend to resolve quickly and are less severe than those associated with COVID-19 infection itself, which can also cause myocarditis. The FDA announcement came as new vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. met to debate the continuing use of COVID-19 vaccines for key groups, including pregnant women. It's the first meeting of the CDC advisory panel since Kennedy abruptly dismissed all 17 members of the group, naming a new panel that includes several members with a history of anti-vaccine statements. The FDA's label update is the latest step by officials working under Kennedy to restrict or undercut use of vaccines. FDA Commissioner Marty Makary and a top deputy recently restricted annual COVID-19 shots to seniors and other Americans at higher risk from the virus. They've also suggested seasonal tweaks to match the latest circulating virus strains are new products that require extra testing. Outside experts said the new warning is the wrong approach. 'They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,' said Dr. Robert Morris, a public health specialist at the University of Washington. 'We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk.' Makary and several other FDA officials gained prominence during the pandemic by suggesting the federal government exaggerated the benefits of COVID-19 boosters and downplayed serious side effects, including myocarditis. Before joining the government, Makary and two of his current FDA deputies wrote a 2022 paper that said mandating booster shots in young people would cause more vaccine-related injuries than prevented hospitalizations from COVID-19 infections. The conclusion contradicted that of many leading vaccine and public health experts at the time, including at the CDC. ___


CNN
11 minutes ago
- CNN
CDC nominee defends Kennedy shakeup of vaccine advisers
Vaccines Federal agencies Water availability Congressional newsFacebookTweetLink Follow US Health and Human Services Secretary Robert F. Kennedy Jr.'s recent move to replace a federal panel of vaccine advisers should help restore Americans' trust in the US Centers for Disease Control and Prevention, the nominee to lead that agency told senators on Wednesday. Dr. Susan Monarez, President Donald Trump's pick for CDC director, testified before the Senate Health, Education, Labor and Pensions Committee amid increasing alarm from lawmakers about Americans' eroding confidence in vaccine safety under Kennedy's leadership of HHS. The Senate hearing happened the same morning that the CDC's newly appointed Advisory Committee on Immunization Practices convened its first meeting in Atlanta despite calls from lawmakers, including HELP Chairman Bill Cassidy, a Republican from Louisiana, to postpone the meeting. 'The secretary had to make a decision related to ensuring that the ACIP could be supportive of restoring public trust,' Monarez said when asked about the reassembled panel. Kennedy dismissed all 17 ACIP members this month, citing conflicts of interest. Two days later, he named eight new members, several of whom had records of criticizing vaccine safety. As of Wednesday morning, one nominee, Dr. Michael Ross, had withdrawn during a federal review of members' financial holdings. Monarez, a microbiologist and infectious disease expert who has served across several federal health agencies over the years, said she was not familiar with the details of the shakeup but would be open to placing more people on the committee. Although the CDC director can recommend experts to join ACIP, the HHS secretary ultimately signs off on appointments. 'These are not easy positions to fill,' Monarez said. 'It takes a lot of time commitment from some of these highly trained technical experts to want to participate.' Cassidy and several Democratic senators sought reassurances from Monarez that she would protect ACIP's integrity as CDC director. 'Part of the concern is that the people on the panel, although scientifically credentialed, no one has the experience of [an] immunization [background] to say, 'Wait a second: The evidence that you're presenting, there's a lot more evidence to say it's not true.' That responsibility will fall on you,' Cassidy said, echoing concerns that he shared about the panel Monday and pointing to a specific presentation, slated for Thursday, on the preservative thimerosal in certain vaccines. Cassidy also brought up mRNA, the technology in widely used Covid-19 vaccines that has early promise in other immunizations and potential therapies. Some vaccine critics, including new ACIP member Dr. Robert Malone, have touted unproven theories that mRNA vaccines can cause cancer and other serious side effects. 'If we turn our back on that platform, we're turning our back on solutions to Lyme disease, which is terribly debilitating, to HIV, which is a scourge,' Cassidy said. He pressed Monarez to include experts on the ACIP panel who have experience with mRNA and immunology. She agreed. 'We absolutely need highly trained scientists and professionals to be able to participate,' Monarez said. ACIP 'is such a vital part of the CDC. It's such a vital, vital process.' The nominee also said several times that 'vaccines save lives.' At other points during the hearing, Monarez distanced herself from other Trump administration directives, including mass layoffs at the CDC and proposals to eliminate certain programs. Monarez, who served as the CDC's deputy director from January to March and later as acting director, said repeatedly that she was not familiar with the details of layoffs that stalled lead poisoning prevention efforts or anti-tobacco education campaigns. Monarez said she was not involved in personnel decisionmaking during those Department of Government Efficiency-led layoff, though she later said she worked with CDC staff to 'make sure we were reinforcing' the reduction in force plans. Kennedy has been critical of the addition of fluoride to public water supplies, but Monarez was more noncommittal when questioned by Maryland Sen. Angela Alsobrooks, a Democrat, about the HHS secretary's plans to end CDC support of fluoridation in state and local drinking water. 'Fluoride is an important component to oral health,' Monarez said. Alsobrooks noted that the public water supply in Potomac, Maryland, where Monarez lives, is fluoridated and asked Monarez whether it is safe. 'I believe the water in Potomac, Maryland, is safe,' Monarez replied. Trump chose Monarez to lead the agency after withdrawing his first nominee, former Florida congressman Dr. Dave Weldon, from consideration. In a public letter after his withdrawal, Weldon accused Cassidy and Sen. Susan Collins of Maine of cratering his nomination amid concerns over his vaccine views.
Yahoo
19 minutes ago
- Yahoo
FDA requires updated warning about rare heart risk with COVID shots
WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men. Myocarditis, a type of heart inflammation that is usually mild, emerged as a complication after the first shots became widely available in 2021. Prescribing information from both Pfizer and Moderna already advises doctors about the issue. In April, the FDA sent letters to both drugmakers asking them to update and expand the warnings to add more detail about the problem and to cover a larger group of patients. While the FDA can mandate label changes, the process is often more of a negotiation with companies. Specifically, the new warning lists the risk of myocarditis as 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old. The label also notes that the problem has been most common among males ages 12 to 24. The previous label said the problem mostly occurs in 12- to 17-year-olds. The FDA's labeling change appears to conflict with some prior findings of scientists elsewhere in the U.S. government. The Centers for Disease Control and Prevention previously concluded there was no increased risk of myocarditis detected in government vaccine injury databases for COVID-19 shots dating back to 2022. Officials also noted that cases tend to resolve quickly and are less severe than those associated with COVID-19 infection itself, which can also cause myocarditis. The FDA announcement came as new vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. met to debate the continuing use of COVID-19 vaccines for key groups, including pregnant women. It's the first meeting of the CDC advisory panel since Kennedy abruptly dismissed all 17 members of the group, naming a new panel that includes several members with a history of anti-vaccine statements. The FDA's label update is the latest step by officials working under Kennedy to restrict or undercut use of vaccines. FDA Commissioner Marty Makary and a top deputy recently restricted annual COVID-19 shots to seniors and other Americans at higher risk from the virus. They've also suggested seasonal tweaks to match the latest circulating virus strains are new products that require extra testing. Outside experts said the new warning is the wrong approach. 'They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,' said Dr. Robert Morris, a public health specialist at the University of Washington. 'We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk.' Makary and several other FDA officials gained prominence during the pandemic by suggesting the federal government exaggerated the benefits of COVID-19 boosters and downplayed serious side effects, including myocarditis. Before joining the government, Makary and two of his current FDA deputies wrote a 2022 paper that said mandating booster shots in young people would cause more vaccine-related injuries than prevented hospitalizations from COVID-19 infections. The conclusion contradicted that of many leading vaccine and public health experts at the time, including at the CDC. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.